Law MG - Search Results

1

Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand.

Teeraananchai S, Kerr SJ, Ruxrungtham K, Avihingsanon A, Chaivooth S, Teeraratkul A, Bhakeecheep S, Ongwandee S, Thanprasertsuk S, Law MG. Teeraananchai S, et al. Among authors: law mg. Antivir Ther. 2018;23(6):529-538. doi: 10.3851/IMP3233. Antivir Ther. 2018. PMID: 29583122

2

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis.

Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM. Grulich AE, et al. Among authors: law mg. AIDS. 2002 May 24;16(8):1155-61. doi: 10.1097/00002030-200205240-00009. AIDS. 2002. PMID: 12004274

3

Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy.

Kirk O, Pedersen C, Law M, Gulick RM, Moyle G, Montaner J, Eron JJ Jr, Phillips AN, Lundgren JD. Kirk O, et al. Antivir Ther. 2002 Dec;7(4):271-81. Antivir Ther. 2002. PMID: 12553482

4

Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings.

Dore GJ, Freeman AJ, Law M, Kaldor JM. Dore GJ, et al. Antivir Ther. 2003 Oct;8(5):365-72. Antivir Ther. 2003. PMID: 14640382 Review.

5

HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.

Duncombe C, Kerr SJ, Ruxrungtham K, Dore GJ, Law MG, Emery S, Lange JM, Phanuphak P, Cooper DA. Duncombe C, et al. Among authors: law mg. AIDS. 2005 Jan 28;19(2):169-78. doi: 10.1097/00002030-200501280-00009. AIDS. 2005. PMID: 15668542

6

Predictors of hypertension and changes of blood pressure in HIV-infected patients.

Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD, Morfeldt L, Fontas E, Kirk O, De Wit S, Calvo G, Law MG, Dabis F, Sabin CA, Lundgren JD; Data Collection of Adverse events of anti-HIV Drugs Study Group. Thiébaut R, et al. Among authors: law mg. Antivir Ther. 2005;10(7):811-23. doi: 10.1177/135965350501000706. Antivir Ther. 2005. PMID: 16315369

7

Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults.

Law M, Puls R, Cheng AK, Cooper DA, Carr A. Law M, et al. Antivir Ther. 2006;11(2):179-86. Antivir Ther. 2006. PMID: 16640099 Clinical Trial.

8

Risk factors and causes of death in the Australian HIV Observational Database.

Petoumenos K, Law MG; Australian HIV Observational Database. Petoumenos K, et al. Among authors: law mg. Sex Health. 2006 May;3(2):103-12. doi: 10.1071/sh05045. Sex Health. 2006. PMID: 16800396

9

Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz.

Boyd MA, Carr A, Ruxrungtham K, Srasuebkul P, Bien D, Law M, Wangsuphachart S, Krisanachinda A, Lerdlum S, Lange JM, Phanuphak P, Cooper DA, Reiss P. Boyd MA, et al. J Infect Dis. 2006 Sep 1;194(5):642-50. doi: 10.1086/505709. Epub 2006 Jul 18. J Infect Dis. 2006. PMID: 16897663

10

Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study.

Lampe FC, Porter K, Kaldor J, Law M, Kinloch-de Loes S, Phillips AN; CASCADE Collaboration. Lampe FC, et al. Antivir Ther. 2007;12(2):189-93. Antivir Ther. 2007. PMID: 17503661 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page